Supraglottic Airway for Resuscitation Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0+
SponsorChildren's Hospital of Philadelphia

About this trial

This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.

Eligibility criteria

Qualifiers

Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation

Fluent in English

Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)

Fluent in English

Disqualifiers

Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation

Fluent in English

Inborn (not transferred to the hospital after birth)

≥34 weeks' gestation at birth, based on best obstetrical estimate

Trial design

Treatments tested in this trial

  • Enhanced Standard of Care ("Enhanced")
  • Enhanced Standard of Care ("Enhanced-Plus")

Treatment groups

36,503 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital of Philadelphia

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator